AMEX:PLX
Director Bar-Shalev Amos sold 168 shares of Protalix BioTherapeutics Inc [PLX]
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or ...
Sharp increase in PLX’s short interest leads to surge in days-to-cover ratio
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its ...
Monitoring Protalix BioTherapeutics Inc (PLX) after recent insider movements
In a filing, Protalix BioTherapeutics Inc revealed its Director Bar-Shalev Amos unloaded Company’s shares for reported $314.0 on Nov 18 ...
Short interest on PLX sees a significant decrease on 2025-11-14
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or ...
Investing in Protalix BioTherapeutics Inc (PLX): What You Must Know
Protalix BioTherapeutics Inc’s recent filing unveils that its Director Schwartz Aharon acquired Company’s shares for reported $0.21 million on Jun ...
PLX (Protalix BioTherapeutics Inc) may reap gains as insiders became active recently
Protalix BioTherapeutics Inc’s recent filing unveils that its Director Schwartz Aharon acquired Company’s shares for reported $0.21 million on Jun ...
An Analysis of Protalix BioTherapeutics Inc (PLX)’s Potential Price Growth
Protalix BioTherapeutics Inc’s filing revealed that its Director Schwartz Aharon acquired Company’s shares for reported $0.21 million on Jun 10 ...
An Analysis of Protalix BioTherapeutics Inc (PLX)’s Potential Price Growth
Protalix BioTherapeutics Inc’s recent filing unveils that its Director Schwartz Aharon acquired Company’s shares for reported $0.21 million on Jun ...
